Overview

Ocular Changes With Alpha-2 Receptor Agonist.

Status:
Recruiting

Trial end date:
2023-09-22

Target enrollment:
0

Participant gender:
All

Summary

selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Benha University

Treatments:

Ophthalmic Solutions

Criteria

Inclusion Criteria:

- Glaucoma suspect cases.

- post-refractive surgery cases.

Exclusion Criteria:

- Cases with prostatic hyperplasia or diabetics that may alter the measurements of
pupillary diameter.

- Cases with previous history of any retinal intervention or other drugs that may alter
intraocular pressure measurements.